Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Fabtech Tech.
Quarter-by-quarter operating performance
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales + | 59 | 104 | 135 | 68 | 121 | 63 | 159 |
| Expenses + | 54 | 81 | 116 | 74 | 91 | 74 | 136 |
| Operating Profit | 5 | 23 | 18 | -6 | 30 | -12 | 22 |
| OPM % | 8% | 22% | 14% | -9% | 25% | -18% | 14% |
| Other Income + | 2 | 2 | 3 | 3 | 3 | 7 | 10 |
| Interest | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 6 | 24 | 20 | -6 | 31 | -7 | 30 |
| Tax % | 15% | 13% | 24% | -1% | 10% | -15% | 26% |
| Net Profit + | 5 | 20 | 15 | -6 | 28 | -6 | 22 |
| EPS in Rs | 1.58 | 6.32 | 4.66 | -1.89 | 8.68 | -1.28 | 4.96 |
Financials of Fabtech Tech.
Annual income statement trend
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales + | 133 | 121 | 257 | 194 | 226 | 327 | 411 |
| Expenses + | 119 | 110 | 225 | 169 | 191 | 288 | 376 |
| Operating Profit | 14 | 11 | 32 | 25 | 35 | 39 | 35 |
| OPM % | 11% | 9% | 12% | 13% | 15% | 12% | 9% |
| Other Income + | 5 | 2 | 4 | 10 | 6 | 27 | 23 |
| Interest | 2 | 2 | 3 | 5 | 3 | 3 | 4 |
| Depreciation | 0 | 0 | 2 | 2 | 2 | 3 | 5 |
| Profit before tax | 16 | 11 | 31 | 28 | 36 | 60 | 48 |
| Tax % | 27% | 29% | 25% | 22% | 24% | 23% | 21% |
| Net Profit + | 12 | 8 | 23 | 22 | 27 | 46 | 38 |
| EPS in Rs | 12,390.00 | 8,040.00 | 84.28 | 78.00 | 92.44 | 14.34 | 8.63 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 7% |
Financials of Fabtech Tech.
Capital structure and asset base
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 3 | 3 | 3 | 32 | 44 |
| Reserves | 38 | 46 | 65 | 86 | 129 | 141 | 375 |
| Borrowings + | 1 | 9 | 21 | 35 | 13 | 84 | 70 |
| Other Liabilities + | 84 | 70 | 83 | 89 | 125 | 170 | 164 |
| Total Liabilities | 123 | 126 | 172 | 214 | 269 | 427 | 654 |
| Fixed Assets + | 2 | 2 | 5 | 4 | 22 | 94 | 78 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 12 | 7 | 17 | 20 | 21 | 15 | 26 |
| Other Assets + | 109 | 116 | 150 | 190 | 226 | 318 | 550 |
| Total Assets | 123 | 126 | 172 | 214 | 269 | 427 | 654 |
Financials of Fabtech Tech.
Operating, investing and financing cash movement
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 64 | -9 | -3 | -14 | 60 | -36 | 0 |
| Cash from Investing Activity + | -28 | 4 | -9 | 2 | -30 | -20 | -112 |
| Cash from Financing Activity + | -23 | 6 | 8 | 12 | -12 | 36 | 190 |
| Net Cash Flow | 13 | 1 | -4 | -0 | 18 | -20 | 78 |
| Free Cash Flow | 64 | -9 | -4 | -14 | 59 | -61 | 5 |
| CFO/OP | 417% | -65% | 4% | -15% | 196% | -68% | 36% |
Financials of Fabtech Tech.
Working capital efficiency and return ratios
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 110 | 135 | 120 | 187 | 156 | 168 | 182 |
| Inventory Days | 22 | 39 | 17 | 69 | 88 | 119 | 32 |
| Days Payable | 82 | 150 | 136 | 215 | 195 | 198 | 159 |
| Cash Conversion Cycle | 51 | 25 | 1 | 41 | 49 | 89 | 55 |
| Working Capital Days | -19 | 15 | 30 | 65 | 63 | 53 | 90 |
| ROCE % | 26% | 48% | 31% | 28% | 22% | 14% |
East India currently 6%, with limited investment so far; future investments may increase contribution. Key concall takeaways from Metropolis Healthcare Ltd's…
IP volume growth for established units guided at roughly 7% to 8%. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q1 FY27 earnings call — and how…
July monthly revenue stood at INR 150+ crores, indicating strong growth momentum. Key concall takeaways from Health X Platform Ltd's Q1 FY27 earnings call…
Shalby MedTech showed strong revenue growth: ₹47 crores in Q1 FY27, a 53% YoY increase. Key concall takeaways from Shalby Ltd's Q1 FY27 earnings call — and how…